IT201700048653A1 - Composti supramolecolari costituiti da acido ialuronico, sodio, amminoacidi essenziali (o non essenziali), acido linoleico, licopene e revestradiolo. - Google Patents

Composti supramolecolari costituiti da acido ialuronico, sodio, amminoacidi essenziali (o non essenziali), acido linoleico, licopene e revestradiolo.

Info

Publication number
IT201700048653A1
IT201700048653A1 IT102017000048653A IT201700048653A IT201700048653A1 IT 201700048653 A1 IT201700048653 A1 IT 201700048653A1 IT 102017000048653 A IT102017000048653 A IT 102017000048653A IT 201700048653 A IT201700048653 A IT 201700048653A IT 201700048653 A1 IT201700048653 A1 IT 201700048653A1
Authority
IT
Italy
Prior art keywords
essential
revestradiol
lycopene
sodium
amino acids
Prior art date
Application number
IT102017000048653A
Other languages
English (en)
Inventor
Gianmarioo Mattei
Original Assignee
Mattei Gianmario
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mattei Gianmario filed Critical Mattei Gianmario
Priority to IT102017000048653A priority Critical patent/IT201700048653A1/it
Priority to PCT/IT2018/000064 priority patent/WO2018203354A2/en
Publication of IT201700048653A1 publication Critical patent/IT201700048653A1/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/01—Hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
    • A61K31/198—Alpha-aminoacids, e.g. alanine, edetic acids [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
IT102017000048653A 2017-05-05 2017-05-05 Composti supramolecolari costituiti da acido ialuronico, sodio, amminoacidi essenziali (o non essenziali), acido linoleico, licopene e revestradiolo. IT201700048653A1 (it)

Priority Applications (2)

Application Number Priority Date Filing Date Title
IT102017000048653A IT201700048653A1 (it) 2017-05-05 2017-05-05 Composti supramolecolari costituiti da acido ialuronico, sodio, amminoacidi essenziali (o non essenziali), acido linoleico, licopene e revestradiolo.
PCT/IT2018/000064 WO2018203354A2 (en) 2017-05-05 2018-05-07 Supramolecular compounds constituted by hyaluronic acid, sodium, essential amino acids and non essential, linoleic acid, lycopene and resveratrol

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT102017000048653A IT201700048653A1 (it) 2017-05-05 2017-05-05 Composti supramolecolari costituiti da acido ialuronico, sodio, amminoacidi essenziali (o non essenziali), acido linoleico, licopene e revestradiolo.

Publications (1)

Publication Number Publication Date
IT201700048653A1 true IT201700048653A1 (it) 2018-11-05

Family

ID=61005883

Family Applications (1)

Application Number Title Priority Date Filing Date
IT102017000048653A IT201700048653A1 (it) 2017-05-05 2017-05-05 Composti supramolecolari costituiti da acido ialuronico, sodio, amminoacidi essenziali (o non essenziali), acido linoleico, licopene e revestradiolo.

Country Status (2)

Country Link
IT (1) IT201700048653A1 (it)
WO (1) WO2018203354A2 (it)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000008061A1 (en) * 1998-08-05 2000-02-17 Jasper Ltd. Liability Co. Reaction products of hyaluronic acid and natural amino acids and their use in cosmetic and pharmaceutical compositions
DE19923829A1 (de) * 1999-05-17 2000-11-23 Ulrich Kluegel Hyaluronat-Wirkstoff-Wasser-Komplex, dessen Herstellung und Verwendung
EP1591105A1 (de) * 2004-03-17 2005-11-02 Stada Arzneimittel Ag Verwendung von Antioxidantien zur Herstellung einer pharmazeutischen oder kosmetischen Zusammensetzung zum Schutz der Haut gegen Schädigung durch Infrarot-Strahlung
DE102004062597A1 (de) * 2004-09-10 2006-03-30 Martin Holzlehner Verfahren zur Mofizierung eines Hyaluronatgeles zu einem supramolekularen Gel. Supramolekulares Hyaluronatgel und dessen Verwendung
WO2007136586A2 (en) * 2006-05-17 2007-11-29 E. I. Du Pont De Nemours And Company Personal care compositions

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20150224069A1 (en) * 2011-08-01 2015-08-13 Tixupharma Method of treatment of periodontum and damaged oral tissue by administering oral compositions comprising supramolecular complexes of polyanionic polymers and spermidine

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000008061A1 (en) * 1998-08-05 2000-02-17 Jasper Ltd. Liability Co. Reaction products of hyaluronic acid and natural amino acids and their use in cosmetic and pharmaceutical compositions
DE19923829A1 (de) * 1999-05-17 2000-11-23 Ulrich Kluegel Hyaluronat-Wirkstoff-Wasser-Komplex, dessen Herstellung und Verwendung
EP1591105A1 (de) * 2004-03-17 2005-11-02 Stada Arzneimittel Ag Verwendung von Antioxidantien zur Herstellung einer pharmazeutischen oder kosmetischen Zusammensetzung zum Schutz der Haut gegen Schädigung durch Infrarot-Strahlung
DE102004062597A1 (de) * 2004-09-10 2006-03-30 Martin Holzlehner Verfahren zur Mofizierung eines Hyaluronatgeles zu einem supramolekularen Gel. Supramolekulares Hyaluronatgel und dessen Verwendung
WO2007136586A2 (en) * 2006-05-17 2007-11-29 E. I. Du Pont De Nemours And Company Personal care compositions

Also Published As

Publication number Publication date
WO2018203354A2 (en) 2018-11-08
WO2018203354A3 (en) 2018-12-13

Similar Documents

Publication Publication Date Title
ECSP17078433A (es) Composiciones de ácido obeticólico y métodos de uso
DK3328843T3 (da) 1,3,4-oxadiazolsulfonamidderivat-forbindelser som histon- deacetylase-6-inhibitor, og den farmaceutske sammensætning
DK3362445T3 (da) Oxadiazolaminderivatforbindelser som histondeacetylase 6-inhibitor, og den farmaceutiske sammensætning dermed
DK3330259T3 (da) 1,3,4-oxadiazolamidderivativ-forbindelse som histondeacetylase-6-inhibitor og farmaceutisk sammensætning indeholdende denne
DK3328844T3 (da) 1,3,4-oxadiazolsulfamidderivater som histondeacetylase-6-inhibitor og farmaceutisk sammensætning omfattende samme
DK3848038T3 (da) 11-Hydroxyl-6substituerede-derivater af galdesyrer og aminosyrerkonjugater heraf som farnesoid X receptor modulerer.
DK3292116T3 (da) 3-aryl-4-amido-bicykliske [4,5,0]hydroxamsyrer som hdac-inhibitorer
BR112017009405A2 (pt) composições antibióticas.
DK3672975T3 (da) Kondenserede, heterocykliske derivater som bcl-2-hæmmere til behandling af neoplastiske sygdomme
DK3313832T3 (da) 3-tetrazolyl-benzen-1,2-disulfonamidderivater som metallo-beta- lactamase-hæmmere
DK3341355T3 (da) (s)-3-amino-4-(difluormethylenyl)cyclopent-1-en-1-carboxylsyre og tilhørende forbindelser som gaba-aminotransferaseinaktivatorer til behandling af epilepsi, afhængighed og hepatocellulært karcinom
DK3870574T3 (da) Aminopyridin/pyrazinderivater som ctps1-inhibitorer
EP3785791A4 (en) ONLINE DOUBLE MEMBRANE GENERATOR FOR ACID OR ALKALINE SOLUTION
DK3782617T3 (da) Farmaceutiske gelsammensætninger omfattende levodopa, carbidopa og entacapon
EP3747932A4 (en) BACTERIOSTATIC AGENT BASED ON BRANCHED POLYAMINOACID AND ITS APPLICATION
EP3681950A4 (en) TRANEXAMIC ACID SPRAY FOR KNEE ARTHROPLASY
EP3658150A4 (en) Isotopically labeled gallic acid derivatives
EP3248981A4 (en) C14-hydroxyl esterified amino acid derivatives of triptolide, and preparation method and use thereof
EP3450483A4 (en) NOVEL ORGANOPOLYSILOXANE OR ACID NEUTRALIZATION SALT THEREOF, AND USES THEREOF
EP3452441A4 (en) ALPHA-TRUXILLIC ACID DERIVATIVES AND ASSOCIATED PHARMACEUTICAL COMPOSITIONS
DK3737470T3 (da) 3-phenyl-4-hexynsyrederivater som gpr40-agonister
MX2015012211A (es) Liquidos ionicos y usos de los mismos.
DK3402573T3 (da) Aminosyreholdig sammensætning
IT201700048653A1 (it) Composti supramolecolari costituiti da acido ialuronico, sodio, amminoacidi essenziali (o non essenziali), acido linoleico, licopene e revestradiolo.
CO2017010018A2 (es) Derivados de ácido (s)-2’-vinil-abscísico